Model Based Iterative Reconstruction, ASIR, and FBP … Adaptive... · ASIR, and FBP in the Same...
Transcript of Model Based Iterative Reconstruction, ASIR, and FBP … Adaptive... · ASIR, and FBP in the Same...
Model Based Iterative Reconstruction, ASIR, and FBP in the Same Patient:
Impact on Image Noise and Image Quality
William P. Shuman MD, FACRUniversity of Washington
SCBTMR Annual Course Washington DC, Oct. 23-26, 2011
Conflict of Interest Statement
• I administer a grant from GE Healthcare which supports clinical investigations in body CT
• No support for equipment or salaries
Generations of CT Reconstruction
Filtered back Projection (FBP)– Assumes “perfect” model
1st Generation
Image Filters & Kernels– Image space approach– Filter noise, Application specific
2nd Generation
Statistical Iterative Reconstruction– Raw Date Recon Approach– Models noise (Photon & Electronic)
3rd Generation
4th GenerationFull Iterative Recon - Model Based– Models CT system geometry – Reconstruct more accurate imagesIQ
Imp
rove
me
nt
& D
ose
Re
du
cti
on
510(k) pending at FDA. Not available for sale in the U.S.
“Idealized” Optics to Real Optics
Filtered Back-Projection
pencil beam
point source
Assumes perfect noise sample
point detector
real source
Real measurementnoise
real detector
Model-Based Iterative Reconstruction
point voxel real 3D voxel
510(k) pending at FDA. Not available for sale in the U.S.
fan beam
Optimize algorithm to run faster on multi-core
processorsMaximize performance
density: more computing powerBlade Center
High-performanceProcessor Technology
Enterprise class blade center with efficient architecture
Proprietary optical modeling algorithm
MBIR Reconstruction
510(k) pending at FDA. Not available for sale in the U.S.
Raw data
SYSTEM NOISE STATISTICS
REAL 3D SYSTEM OPTICS
noise vs. detail low dose, detail lower dose and better detail
SYSTEM NOISE
STATISTICS
Statistical Model-based
Rapid Rapid 30+ mins
510(k) pending at FDA. Not available for sale in the U.S.
Evolution of Image Reconstruction
FBPDirect Reconstruction
FBP ASIR MBIR
120 kVp, variable mAs (NI=36), 1.375 pitch. 0.625/0.8 mm slice: Width = 400, Level = 40 HU, BMI=33Kinahan et al
Soft Tissue ConspicuityIncreased noise Increased conspicuity
Three-phase liver
FBP
MBIR
Arterial Venous 5 min delay
120 kVp, variable mAs (NI=36), 1.375 pitch. 0.8 mm slice: Width = 400, Level = 40 HU, BMI=25
Kinahan et al
Liver: FBP vs ASIR vs MBIR
• 36 cirrhosis patients with known liver lesions• Scanned with low-dose ATCM (NI = 36)
• Clinically optimized for 40% ASIR• kVp 120, BMI up to 35
• Raw data from late-arterial phase reconstructed with FBP, 40% ASIR, MBIR
• Images shown to 2 independent readers• Identify lesions• Characterize as hyperdense, hypodense, mixed• Score lesion conspicuity
Liver: FBP vs ASIR vs MBIR
• Lesion, liver HU density measured
• Noise measured in liver, air, fat, aorta
• Three separate “Truth Readers”• Unblinded – looked at all reconstructions, EMR,
comparison studies• Established lesion number, character, location
MBIR ASIR FBP
Arterial
Delayed
MBIR ASIR FBP
Arterial
Delayed
Liver: FBP vs ASIR vs MBIR
• Preliminary Results:
• Apparent equal lesion detection among the reconstruction types (51 lesions)
• Apparent equal lesion characterization among the reconstruction types
• Subjective lesion conspicuity appears slightly better on MBIR
Liver: FBP vs ASIR vs MBIR
• Preliminary Results:
• Background noise in air for MBIR was one quarter that of ASIR and one fifth of FBP
• Contrast-to-noise ration for MBIR was five times greater than ASIR and six times greater than FBP
Conclusion :
• When CT scanning factors are optimized for 40% ASIR:• Recon of the same raw data set with MBIR,
ASIR and FBP results in subjectively comparable liver lesion detectability, lesion characterization, and lesion conspicuity
• Measured image noise is dramatically lower with MBIR and measured lesion CNR is much greater
Conclusion :
• Suggests that when CT scanning factors are optimized for MBIR, patient radiation dose can be much lower (~ 80 to 90% lower)
MBIR FBPASIR
100 kVp, 25-38 mA, 0.4 sec
Images courtesy of Pr Maher, Cork University Hospital, Ireland 510(k) pending at FDA Not available for sale in the U.S.
Low Dose abdomen + pelvis - 0.6 mSv
39 cm